房颤患者左心耳封堵与口服抗凝预防卒中或体循环栓塞的更新荟萃分析
该荟萃分析纳入截至2026年4月7日的6项随机对照试验,共7004例房颤患者,比较左心耳封堵与口服抗凝。结果显示两组卒中或体循环栓塞风险无显著差异,但左心耳封堵缺血性卒中或体循环栓塞风险更高,非操作相关出血风险更低。
要点
- 左心耳封堵与口服抗凝的卒中或体循环栓塞风险无显著差异
- 左心耳封堵缺血性卒中或体循环栓塞风险显著高于口服抗凝
- 左心耳封堵非操作相关出血风险显著低于口服抗凝
核心结论
- 左心耳封堵与口服抗凝在卒中或体循环栓塞及大出血风险方面相当
- 左心耳封堵缺血性卒中或体循环栓塞风险更高,但非操作相关出血风险更低
研究设计与样本
- 检索三个数据库截至2026年4月7日的随机对照试验
- 纳入6项随机对照试验共7004例房颤患者
- 采用随机效应模型合并风险比及95%置信区间
主要发现
- 卒中或体循环栓塞风险在两组间无显著差异,RR为1.10,95%CI为0.87至1.39,P为0.42
- 缺血性卒中或体循环栓塞风险在左心耳封堵组显著增加,RR为1.41,95%CI为1.07至1.85,P为0.02
- 全因死亡风险在两组间无显著差异,RR为0.94,95%CI为0.81至1.09
- 心血管死亡风险在两组间无显著差异,RR为0.91,95%CI为0.69至1.21
- 非心血管死亡风险在两组间无显著差异,RR为0.91,95%CI为0.75至1.12
临床怎么用
- 左心耳封堵可用于长期出血风险高的特定房颤患者
- 治疗决策应强调个体化共同决策
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Introduction Left atrial appendage closure (LAAC) is an emerging alternative for stroke prevention in patients with atrial fibrillation (AF) who are unsuitable for long-term oral anticoagulants (OACs). However, its efficacy and safety relative to OACs remain uncertain. Methods Three databases were searched up to April 7, 2026, for randomized controlled trials comparing LAAC with OAC in patients with AF. Risk ratios with 95% confidence intervals were pooled using a random-effects model. Results Six RCTs (n = 7004 patients) were analyzed. The risk of stroke or systemic embolism (SSE) did not differ significantly between the LAAC and OAC groups (RR: 1.10 [0.87–1.39]; p = 0.42). The risk of ischemic SSE was significantly increased with LAAC (RR: 1.41 [1.07–1.85]; p = 0.02) compared with OAC. No significant differences were observed in all-cause mortality (RR: 0.94 [0.81–1.09]), cardiovascular mortality (RR: 0.91 [0.69–1.21]), non-cardiovascular mortality (RR: 0.91 [0.75–1.12]), or hemorrhagic stroke (RR: 0.58 [0.29–1.17]). LAAC was associated with a similar risk of overall major bleeding (RR: 0.92 [0.77–1.09]) and low risk of non-procedural bleeding (RR: 0.61 [0.52–0.73]; p < 0.001) compared with OAC. Upon sensitivity analysis comparing LAAC with DOACs, the findings remained consistent across most clinical outcomes. Conclusion LAAC demonstrates comparable risks of SSE and major bleeding to OACs, but is associated with a higher risk of ischemic SSE and reduced non-procedural bleeding, supporting its use in selected patients at high risk for long-term bleeding while emphasizing individualized shared decision-making.
引用
- Journal of Cardiovascular Electrophysiology:Left Atrial Appendage Closure Versus Oral Anticoagulation for Prevention of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: An Updated Meta‐Analysis of 7004 Patients Across Six Randomized Trials
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。